Constellation Brands
STZ
DexCom
DXCM
Lantheus
LNTH
New Fortress Energy
NFE
Halozyme Therapeutics
HALO
(Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -89.26%18.03K | -95.36%49.2K | -95.36%49.2K | -95.80%53.49K | -91.16%123.88K | -88.85%167.95K | -36.01%1.06M | -36.01%1.06M | -27.38%1.27M | -18.59%1.4M |
-Cash and cash equivalents | -89.26%18.03K | -95.36%49.2K | -95.36%49.2K | -95.80%53.49K | -91.16%123.88K | -88.85%167.95K | -36.01%1.06M | -36.01%1.06M | -27.38%1.27M | -18.59%1.4M |
Receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --73.8K | --0 |
-Taxes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --73.8K | --0 |
Prepaid assets | 97.68%210.18K | 27.92%177.26K | 27.92%177.26K | 58.37%48.33K | -6.91%62.45K | 1.66%106.32K | -46.21%138.57K | -46.21%138.57K | -76.30%30.51K | -61.11%67.08K |
Total current assets | -16.79%228.21K | -81.12%226.46K | -81.12%226.46K | -92.61%101.82K | -87.32%186.33K | -82.98%274.27K | -37.38%1.2M | -37.38%1.2M | -26.81%1.38M | -22.46%1.47M |
Non current assets | ||||||||||
Non current deferred assets | --61.28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current assets | -79.31%12.69M | -93.53%12.63M | -93.53%12.63M | -93.59%13.19M | -93.54%13.23M | -69.93%61.33M | -3.75%195.31M | -3.75%195.31M | 1.82%205.83M | 1.77%204.89M |
Total non current assets | -79.21%12.75M | -93.53%12.63M | -93.53%12.63M | -93.59%13.19M | -93.54%13.23M | -69.93%61.33M | -3.75%195.31M | -3.75%195.31M | 1.82%205.83M | 1.77%204.89M |
Total assets | -78.93%12.98M | -93.46%12.85M | -93.46%12.85M | -93.59%13.29M | -93.50%13.41M | -70.03%61.6M | -4.06%196.51M | -4.06%196.51M | 1.56%207.21M | 1.54%206.36M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | ---- | -59.82%452.1K | 4.79%793.6K | ---- | ---- | ---- | 221.01%1.13M | 498.19%757.34K |
-accounts payable | ---- | ---- | ---- | -70.99%326.43K | -78.04%163.69K | ---- | ---- | ---- | 221.32%1.13M | 488.89%745.55K |
-Total tax payable | ---- | ---- | ---- | --125.68K | 5,245.05%629.91K | ---- | ---- | ---- | ---- | --11.79K |
Current accrued expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
Current liabilities | -90.87%319.18K | -90.60%260.4K | -90.60%260.4K | -59.82%452.1K | 4.79%793.6K | 802.32%3.49M | 532.82%2.77M | 532.82%2.77M | 213.29%1.13M | 459.98%757.34K |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -70.63%460K | 39.73%791.29K | 39.73%791.29K | --566.27K | --566.27K | --1.57M | --566.29K | --566.29K | ---- | ---- |
-Long term debt | -70.63%460K | 39.73%791.29K | 39.73%791.29K | --566.27K | --566.27K | --1.57M | --566.29K | --566.29K | ---- | ---- |
Non current deferred liabilities | -71.43%2M | -3.57%6.75M | -3.57%6.75M | -0.13%7M | -0.19%7M | 0.00%7M | -0.03%7M | -0.03%7M | 0.13%7.01M | 0.19%7.01M |
Due to related parties non current | ---- | ---- | ---- | ---- | ---- | --40M | ---- | ---- | ---- | ---- |
Derivative product liabilities | --8.31M | -12.65%6.26M | -12.65%6.26M | ---- | ---- | ---- | --7.17M | --7.17M | ---- | ---- |
Total non current liabilities | -77.83%10.77M | -6.32%13.8M | -6.32%13.8M | 7.95%7.57M | 7.89%7.57M | 593.80%48.57M | 110.41%14.73M | 110.41%14.73M | 0.13%7.01M | 0.19%7.01M |
Total liabilities | -78.70%11.09M | -19.66%14.06M | -19.66%14.06M | -1.42%8.02M | 7.59%8.36M | 604.73%52.06M | 135.27%17.5M | 135.27%17.5M | 10.53%8.13M | 8.90%7.77M |
Shareholders'equity | ||||||||||
Share capital | -99.99%622 | -100.00%622 | -100.00%622 | -99.86%271.62K | -99.97%52.81K | -97.65%4.54M | -9.56%174.01M | -9.56%174.01M | 1.26%194.08M | 1.31%193.59M |
-common stock | -99.99%622 | -100.00%622 | -100.00%622 | -99.86%271.62K | -99.97%52.81K | -97.65%4.54M | -9.56%174.01M | -9.56%174.01M | 1.26%194.08M | 1.31%193.59M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -238.56%-2.92M | -783.41%-1.21M | -783.41%-1.21M | 30.74%4.94M | 43.57%4.72M | -26.50%2.11M | -106.54%-136.71K | -106.54%-136.71K | 176.05%3.78M | 315.91%3.29M |
Paid-in capital | 66.38%4.81M | --0 | --0 | -94.82%63.39K | -83.53%282.2K | 35.63%2.89M | 76.58%5.14M | 76.58%5.14M | -66.30%1.22M | -59.29%1.71M |
Total stockholders'equity | -80.15%1.89M | -100.67%-1.21M | -100.67%-1.21M | -97.35%5.27M | -97.46%5.05M | -95.19%9.54M | -9.31%179.01M | -9.31%179.01M | 1.22%199.08M | 1.27%198.59M |
Total equity | -80.15%1.89M | -100.67%-1.21M | -100.67%-1.21M | -97.35%5.27M | -97.46%5.05M | -95.19%9.54M | -9.31%179.01M | -9.31%179.01M | 1.22%199.08M | 1.27%198.59M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |